Evidence map›Paper›PMID 39749010›Full record

ArticleBrain communications2025

Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge.

Emre Fertan, Christy Hung, John S H Danial, Jeff Y L Lam, Pranav Preman, Giulia Albertini, Elizabeth A English, Dorothea Böken, Frederick J Livesey, Bart De Strooper and 2 more

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Beyond prion-like spreading in neurodegenerative disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  9. Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  10. Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emre FertanYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.ORCID https://orcid.org/0000-0002-0060-5806
Christy HungThe Francis Crick Institute, University College London, London NW1 1AT, UK.ORCID https://orcid.org/0000-0003-0056-7587
John S H DanialYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.ORCID https://orcid.org/0000-0002-9882-8441
Jeff Y L LamYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
Pranav PremanVIB-KU Leuven Center for Brain & Disease Research, Herestraat 49, 0N5 box 602, 3000 Leuven, Belgium.
Giulia AlbertiniVIB-KU Leuven Center for Brain & Disease Research, Herestraat 49, 0N5 box 602, 3000 Leuven, Belgium.
Elizabeth A EnglishYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
Dorothea BökenYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.ORCID https://orcid.org/0009-0008-8443-4469
Frederick J LiveseyZayed Centre for Research into Rare Disease in Children, University College London, Great Ormond Street Institute of Child Health, London WC1N 1DZ, UK.
Bart De StrooperVIB-KU Leuven Center for Brain & Disease Research, Herestraat 49, 0N5 box 602, 3000 Leuven, Belgium.
Rickie PataniThe Francis Crick Institute, University College London, London NW1 1AT, UK.ORCID https://orcid.org/0000-0002-3825-7675
David KlenermanYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular beta-amyloid aggregation and inflammation are in a complex and not fully understood interplay during hyperphosphorylated tau aggregation and pathogenesis of Alzheimer's disease. Our group has previously shown that an immune challenge with tumour necrosis factor alpha can alter extracellular beta-sheet containing aggregates in human-induced pluripotent stem cell-derived cortical neurons carrying familial Alzheimer's disease-related presenilin 1 mutations. Here, using single-molecule detection and super-resolution imaging techniques, we quantified and characterized the intra- and extracellular beta-amyloid and AT8-positive tau aggregates. Our results indicate a pre-existing Alzheimer's disease-like pathology caused by the presenilin 1 mutation, with increased beta-amyloid aggregates in both the cell lysate and conditioned media compared to isogenic controls and also increased intracellular tau aggregates. The main effect of tumour necrosis factor alpha treatment on presenilin 1 neurons was the formation of larger intracellular beta-amyloid aggregates. In contrast, isogenic controls showed more significant changes with tumour necrosis factor alpha treatment with an increase in beta-amyloid aggregates in the media but not intracellularly and an increase in tau aggregates in both the media and cell lysate, suggesting a chronic inflammation-driven mechanism for the development of sporadic Alzheimer's disease. Remarkably, we also found significant morphological differences between intra- and extracellular beta-amyloid and tau aggregates in human-induced pluripotent stem cell-derived cortical neurons, suggesting these neurons can only clear aggregates when small, and that larger aggregates stay inside the neurons. While majority of the beta-amyloid aggregates were cleared into the media, a greater portion of the tau aggregates remained intracellular. This size-dependent aggregate clearance was also shown to be conserved

Indexed as

Alzheimer’s diseaseconditioned mediainduced pluripotent stem cellsingle-molecule detectionsuper-resolution microscopy

Identifiers

PMID39749010
PMCPMC11694676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.